Alfuzosin + Dutasteride in pharma franchise in Odisha

Alfuzosin + Dutasteride in PCD pharma franchise in Aizawl

Alfuzosin + Dutasteride in top pharma company in Allahabad

Alfuzosin + Dutasteride in pcd pharma supplier in Shimla

Alfuzosin + Dutasteride in phama franchise company in India
Alfuzosin + Dutasteride in phama distributor in Kollam

Home/Products /alfuzosin-10mg-dutasteride-0-point-5mg-tablet

Alfuxyle D PR Tablet

Composition : Alfuzosin (10mg) + Dutasteride (0.5mg) Tablet

Dosage Form : Tablet

Packaging Type : Alu Alu

Packaging : 10*10

Price : ₹299/-

Alfuxyle D Tablet is a combination medication designed to manage benign prostatic hyperplasia (BPH), a condition characterized by an enlarged prostate gland that causes urinary difficulties. Alfuzosin is an alpha-adrenergic blocker that works by relaxing the smooth muscles in the bladder neck and prostate, improving urine flow and reducing symptoms such as frequent or incomplete urination. Dutasteride is a 5-alpha-reductase inhibitor that reduces the size of the prostate gland by lowering dihydrotestosterone (DHT) levels, which are responsible for prostate growth.

This dual-action formula provides symptomatic relief while addressing the underlying cause of prostate enlargement. Alfuxyle D Tablet helps reduce the risk of acute urinary retention and the need for surgical intervention in patients with BPH. It is particularly suitable for men experiencing moderate to severe urinary symptoms due to prostate enlargement.

The medication is effective when taken consistently as prescribed, and results are usually observed over a few weeks of treatment. Regular follow-up with a healthcare professional is essential to monitor the prostate size and ensure optimal therapeutic outcomes.

Read More

About the Product

Alfuxyle D Tablet is a combination medication designed to manage benign prostatic hyperplasia (BPH), a condition characterized by an enlarged prostate gland that causes urinary difficulties. Alfuzosin is an alpha-adrenergic blocker that works by relaxing the smooth muscles in the bladder neck and prostate, improving urine flow and reducing symptoms such as frequent or incomplete urination. Dutasteride is a 5-alpha-reductase inhibitor that reduces the size of the prostate gland by lowering dihydrotestosterone (DHT) levels, which are responsible for prostate growth.

This dual-action formula provides symptomatic relief while addressing the underlying cause of prostate enlargement. Alfuxyle D Tablet helps reduce the risk of acute urinary retention and the need for surgical intervention in patients with BPH. It is particularly suitable for men experiencing moderate to severe urinary symptoms due to prostate enlargement.

The medication is effective when taken consistently as prescribed, and results are usually observed over a few weeks of treatment. Regular follow-up with a healthcare professional is essential to monitor the prostate size and ensure optimal therapeutic outcomes.

Common side effects include dizziness, headache, fatigue, or decreased libido. Rarely, it may cause erectile dysfunction or breast tenderness.

Indicated for the management of benign prostatic hyperplasia (BPH), improving urinary flow, and reducing prostate size.

This medication is intended for use by men only. Avoid use in women and children. Consult a healthcare professional if symptoms persist or worsen. Avoid driving or operating heavy machinery if dizziness occurs.

Store in a cool, dry place at room temperature. Protect from moisture and direct sunlight. Keep out of reach of children.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Strategic Advisory

Ms. Shiwani Dhiman

VP-Strategic Outreach & Engagement

Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.

View Professional Profile

Start Your Journey

Partner With Cafoli

Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our rapidly growing network of successful franchise partners and turn your ambitions into reality. Limited Territories Available — Don’t Miss Out!

Quick Navigation